IGF2 and breast carcinoma: In breast cancer cells, a positive feedback mechanism was demonstrated when IGF2 binds to IGF1 receptors, triggering PI3K/AKT1 signaling and leading to the activation of DNA-binding protein inhibitor ID1, a transcriptional factor that acts not only on the maintenance of stemness but also on the positive regulation of IGF2 [42].